Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/11057
DC FieldValueLanguage
dc.contributor.authorSvetlana Stankovicen_US
dc.contributor.authorLidija Cevreskaen_US
dc.contributor.authorAleksandar Stojanovicen_US
dc.contributor.authorTatjana Smilevskaen_US
dc.contributor.authorBorce Georgievskien_US
dc.contributor.authorOliver Karanfilskien_US
dc.date.accessioned2021-03-18T11:59:24Z-
dc.date.available2021-03-18T11:59:24Z-
dc.date.issued2006-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/11057-
dc.language.isoenen_US
dc.relation.ispartofTurkish Journal of Hematologyen_US
dc.subjectBortezomiben_US
dc.subjectmultiple myelomaen_US
dc.subjectrefractory diseaseen_US
dc.titleOur initial experience with Bortezomib in the treatment of refractory myelomaen_US
dc.typeProceeding articleen_US
dc.relation.conference1st balkan Hematology Days, Antalya, Turkey, Nov 10-11, 2006en_US
item.fulltextWith Fulltext-
item.grantfulltextopen-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Conference papers
Files in This Item:
File Description SizeFormat 
Turkish Society of Hematology.jpg130.8 kBJPEGThumbnail
View/Open
Turkish Journal of Hematology.jpg178.62 kBJPEGThumbnail
View/Open
poster BSH004 i BSH005.jpg230.59 kBJPEGThumbnail
View/Open
Show simple item record

Page view(s)

36
checked on Aug 8, 2024

Download(s)

30
checked on Aug 8, 2024

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.